Anderson Silva flunks post-fight drug test

MANILA, Philippines – Former Ultimate Fighting Championship (UFC) middleweight titleholder Anderson Silva failed the post-fight drug test after his lopsided decision victory over Nick Diaz at UFC 183 last January 31 (February 1 Manila time).

The Nevada State Athletic Commission released the information ahead of its closed-door meeting on Wednesday, February 18 (Manila Time) that Silva was caught using three prohibited substances through a urine sample.

Silva tested positive for drostanolone metabolites, an anabolic steroid that has been mainly used for bodybuilding.

Drostanolone is the same drug that was initially found in the system of the 39-year-old Silva during his out-of-competition screening on January 9.

Aside from drostanolone, anti-anxiety medicines Oxazepam and Temazepam were also present in his body.

Oxazepam has been used extensively since the 1960s for the treatment of anxiety, while Temazepam is labeled as an anti-insomnia medication.

All three substances are banned by the World Anti-Doping Agency code, which is followed by the sanctioning committee.

Due to the results of his drug exam, NSAC handed Silva a temporary suspension that will require the Brazilian to attend a future disciplinary hearing, where fines and long-term suspensions will likely be issued.

Silva had already dismissed NSAC’s findings and promised to cooperate with the commission.

– Rappler.com